Erschienen in:
12.02.2022 | Original Article
Lymphocytes Utilize Somatic Mutations, Epigenetic Silencing, and the Proteasome to Escape Truncated WASP Expression
verfasst von:
Caroline Khanna, Carole Le Coz, Courtney Vaccaro, Piyush Pillarisetti, Ainsley V. C. Knox, Andrew Sy, Edward M. Behrens, David Buchbinder, Neil Romberg
Erschienen in:
Journal of Clinical Immunology
|
Ausgabe 4/2022
Einloggen, um Zugang zu erhalten
Abstract
Wiskott-Aldrich Syndrome Protein (WASP) deficiency causes Wiskott-Aldrich Syndrome (WAS), a sex-linked disorder characterized by combined immunodeficiency, microthrombocytopenia, and eczema. Like WASP-deficient humans, WASP-deficient mice produce normal numbers of functionally defective T cells. Here, we report a WAS patient with a novel germline frameshifting WAS mutation encoding a truncated form of WASP lacking the C-terminal cofilin homology (C) and the acidic region (A) domains (WASPΔCA). Although stably overexpressed in embryonic kidney cell lines, WASPΔCA was undetectable in circulating patient leukocytes. Deep sequencing, transcript profiling, and protein degradation analyses demonstrated patient lymphocytes employ an array of genetic, epigenetic, and proteasomal strategies to avoid expressing WASPΔCA.